File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1073/pnas.1314826111
- Scopus: eid_2-s2.0-84893357959
- PMID: 24474789
- WOS: WOS:000330231100087
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation
Title | ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation |
---|---|
Authors | |
Keywords | Activating Transcription Factor 3/*metabolism Amyotrophic Lateral Sclerosis/pathology/*physiopathology Animals Cell Survival Disease Models, Animal Mice Motor Neurons/*pathology Muscle, Skeletal/*innervation Superoxide Dismutase/genetics |
Issue Date | 2014 |
Publisher | National Academy of Sciences. The Journal's web site is located at http://www.pnas.org |
Citation | Proceedings of the National Academy of Sciences, 2014, v. 111 n. 4, p. 1622-1627 How to Cite? |
Abstract | ALS is a fatal neurodegenerative disease characterized by a progressive loss of motor neurons and atrophy of distal axon terminals in muscle, resulting in loss of motor function. Motor end plates denervated by axonal retraction of dying motor neurons are partially reinnervated by remaining viable motor neurons; however, this axonal sprouting is insufficient to compensate for motor neuron loss. Activating transcription factor 3 (ATF3) promotes neuronal survival and axonal growth. Here, we reveal that forced expression of ATF3 in motor neurons of transgenic SOD1G93A ALS mice delays neuromuscular junction denervation by inducing axonal sprouting and enhancing motor neuron viability. Maintenance of neuromuscular junction innervation during the course of the disease in ATF3/SOD1G93A mice is associated with a substantial delay in muscle atrophy and improved motor performance. Although disease onset and mortality are delayed, disease duration is not affected. This study shows that adaptive axonal growth-promoting mechanisms can substantially improve motor function in ALS and importantly, that augmenting viability of the motor neuron soma and maintaining functional neuromuscular junction connections are both essential elements in therapy for motor neuron disease in the SOD1G93A mice. Accordingly, effective protection of optimal motor neuron function requires restitution of multiple dysregulated cellular pathways. |
Persistent Identifier | http://hdl.handle.net/10722/219919 |
ISSN | 2023 Impact Factor: 9.4 2023 SCImago Journal Rankings: 3.737 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seijffers, R | - |
dc.contributor.author | Zhang, J | - |
dc.contributor.author | Matthews, JC | - |
dc.contributor.author | Chen, A | - |
dc.contributor.author | Tamrazian, E | - |
dc.contributor.author | Babaniyi, O | - |
dc.contributor.author | Selig, M | - |
dc.contributor.author | Hynynen, M | - |
dc.contributor.author | Woolf, CJ | - |
dc.contributor.author | Brown, RH | - |
dc.date.accessioned | 2015-10-02T09:00:02Z | - |
dc.date.available | 2015-10-02T09:00:02Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Proceedings of the National Academy of Sciences, 2014, v. 111 n. 4, p. 1622-1627 | - |
dc.identifier.issn | 0027-8424 | - |
dc.identifier.uri | http://hdl.handle.net/10722/219919 | - |
dc.description.abstract | ALS is a fatal neurodegenerative disease characterized by a progressive loss of motor neurons and atrophy of distal axon terminals in muscle, resulting in loss of motor function. Motor end plates denervated by axonal retraction of dying motor neurons are partially reinnervated by remaining viable motor neurons; however, this axonal sprouting is insufficient to compensate for motor neuron loss. Activating transcription factor 3 (ATF3) promotes neuronal survival and axonal growth. Here, we reveal that forced expression of ATF3 in motor neurons of transgenic SOD1G93A ALS mice delays neuromuscular junction denervation by inducing axonal sprouting and enhancing motor neuron viability. Maintenance of neuromuscular junction innervation during the course of the disease in ATF3/SOD1G93A mice is associated with a substantial delay in muscle atrophy and improved motor performance. Although disease onset and mortality are delayed, disease duration is not affected. This study shows that adaptive axonal growth-promoting mechanisms can substantially improve motor function in ALS and importantly, that augmenting viability of the motor neuron soma and maintaining functional neuromuscular junction connections are both essential elements in therapy for motor neuron disease in the SOD1G93A mice. Accordingly, effective protection of optimal motor neuron function requires restitution of multiple dysregulated cellular pathways. | - |
dc.language | eng | - |
dc.publisher | National Academy of Sciences. The Journal's web site is located at http://www.pnas.org | - |
dc.relation.ispartof | Proceedings of the National Academy of Sciences | - |
dc.subject | Activating Transcription Factor 3/*metabolism | - |
dc.subject | Amyotrophic Lateral Sclerosis/pathology/*physiopathology | - |
dc.subject | Animals | - |
dc.subject | Cell Survival | - |
dc.subject | Disease Models, Animal | - |
dc.subject | Mice | - |
dc.subject | Motor Neurons/*pathology | - |
dc.subject | Muscle, Skeletal/*innervation | - |
dc.subject | Superoxide Dismutase/genetics | - |
dc.title | ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation | - |
dc.type | Article | - |
dc.identifier.email | Zhang, J: jzhang1@hku.hk | - |
dc.identifier.authority | Zhang, J=rp01713 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1073/pnas.1314826111 | - |
dc.identifier.pmid | 24474789 | - |
dc.identifier.pmcid | PMC3910594 | - |
dc.identifier.scopus | eid_2-s2.0-84893357959 | - |
dc.identifier.hkuros | 291160 | - |
dc.identifier.volume | 111 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 1622 | - |
dc.identifier.epage | 1627 | - |
dc.identifier.isi | WOS:000330231100087 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 0027-8424 | - |